Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Glioblastoma × antisecretory factor × Clear all

Phase

Status

Recruiting 2 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Glioblastoma 1 Brain Edema 1

Interventions

Temozolomide 181 Radiotherapy 105 Bevacizumab 79 Radiation 35 Magnetic Resonance Spectroscopy 25 Irinotecan 24 Carmustine 23 Surgical Procedures, Operative 20 Lomustine 19 Erlotinib Hydrochloride 16 Chemotherapy, Adjuvant 15 Carboplatin 15 sargramostim 11 Drug Therapy 11 Radiosurgery 10 O(6)-benzylguanine 10 temsirolimus 9 Vorinostat 9 Radiotherapy, Intensity-Modulated 9 Radiotherapy, Conformal 9 Everolimus 9 pembrolizumab 8 motexafin gadolinium 8 Thalidomide 8 Sorafenib 8 Nivolumab 8 Imatinib Mesylate 8 cediranib 7 IL13-PE38 7 Gene Expression Profiling 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04116138 2021-04-28

AFGBM1

Skane University Hospital

Phase 1/2 Completed

Brain Edema, Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡